This modification exerts selective control over the selective translation of oncogenic mRNAs governed by a codon frequency–dependent mechanism, primarily orchestrated by the METTL1/WDR4 complex, thereby influencing tumour growth and malignancy. The gene discussed is METTL1; the disease is neoplasm.